| Literature DB >> 23300560 |
Dominik Ose1, Justine Rochon, Stephen M Campbell, Michel Wensing, Jan van Lieshout, Lorenz Uhlmann, Tobias Freund, Joachim Szecsenyi, Sabine Ludt.
Abstract
BACKGROUND: For patients with coronary heart diseases a substantial part of secondary prevention is delivered in primary care. Along with the growing importance of prevention, health-related quality of life (HRQoL) is an indicator of patient-centered care that has gained increased attention. Different approaches for reorganization in primary care have been associated with improvements in HRQoL. However, these are often results of complex interventions. Evidence on aspects concerning usual primary care that actually have an impact on HRQoL remains scarce. Therefore, this observational study aimed to identify factors which are associated with HRQoL in usual primary care at practice and patient-level.Entities:
Mesh:
Year: 2012 PMID: 23300560 PMCID: PMC3530503 DOI: 10.1371/journal.pone.0051726
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Data flowchart.
Inclusion and exclusion criteria for patients with CHD.
| Inclusion criteria | Exclusion criteria |
| Documented diagnosis, ICD 10 code: I20-I25, ICPC-2 code: K74-76 | Terminal illness, cognitive disorders (e.g. dementia), psychiatric diseases (e.g. schizophrenia) and lack of language knowledge |
Explanatory variables included in the multilevel analysis.
| Variables | Categories/Scoring |
|
| |
| Quality-management score | Continuous: sum score of ‘yes-answers’; range: 0–15 |
| CVD-care score | Continuous: sum score of ‘yes-answers’; range: 0–17 |
|
| |
|
| |
| Gender | 2 categories: female; male |
| Age | Continuous: age divided by 5 |
| Marital status | 2 categories: married/cohabitating; single/separated/divorced/widowed |
| Education | Years in school; 2 categories : ≤9 years; >9 years |
| Number of other conditions | Continuous: sum score (range: 0–11) of all patient reported symptoms or conditions including ‘high blood pressure’, ‘high cholesterol’, ‘diabetes’, ‘angina’, ‘history of heart attack’, ‘history of PCI or bypass’, ‘symptoms of heart failure’, ‘transient ischemic attacks’, ‘history of stroke’, ‘peripheral artery disease’ or ‘symptoms of depression’ |
| Body Mass Index | 2 categories: up to 30; more than 30 |
|
| |
| Being patient in practice | 3 categories: up to 2 years; 3 to 7 years; more than 7 years |
| Practice attendance last year | 3 categories: up to 3 times/year; 4 to 7 times/year; more than 7 times/year |
| Referral to exercise program | 2 categories: Yes; No/don't Know |
| Medication adherence (Morisky) | Continuous sum score (4 items): 0–4 (best) |
| Patient satisfaction (EUROPEP) | |
| Clinical behavior | Continuous: (EUROPEP dimension ‘clinical behavior’ 16 items) mean: 1–5 (best) |
| Organization of care | Continuous: (EUROPEP dimension ‘organization of care’ 7 items) mean: 1–5 (best): |
Practice characteristics.
| Quality management (15 items) |
| • Does the practice use a computer-supported patient file system? |
| • Is the computer used for creating medication prescriptions? |
| • Does the practice have a procedure for the management of patient information in relation to detailed examination results and the documentation of measures that were taken (e.g., blood examinations)? |
| • Does the practice have a procedure for the management of patient information in relation to the review of detailed examination results by the doctor (in terms of outgoing needs)? |
| • Do the practice doctors have direct access to medical guidelines (either on paper or electronic) in their treatment rooms? |
| • In general: Is practice staff allowed to contact or recall patients? |
| • Does the practice produce a quality report? |
| • Has the practice undertaken at least one clinical audit in the last 12 months? |
| • Did you set standards regarding this clinical audit (defined the target)? |
| • Did you collect data regarding this clinical audit? |
| • Did you evaluate the result? |
| • Were you able to improve the quality regarding this clinical audit topic? |
| • Does the practice have a critical incident register? |
| • Did the practice have a team meeting about quality improvement relating to CVD at least once in the last 15 months? |
| • Did the practice participate in cardiovascular quality improvement projects? |
Sample description (included patients).
| Total sample | Single practice | Group practice | p-value | ||||
|
| |||||||
| Included practices | 228 | 113 | 102 | ||||
| FTE GP (SD) | 2.04 (1.70) | 1.00 (0.04) | 3.20 (1.89) | ||||
| Practice town (>100.000 inhabitants) (%) | 69 (30.7) | 27 (23.9) | 39 (39.4) | .0150 | |||
| CVD-care score (SD) | 8.24 (4.72) | 6.80 (3.97) | 9.79 (5.05) | <.0001 | |||
| Quality-management score (SD) | 9.00 (3.87) | 8.05 (3.40) | 10.42 (3.93) | <.0001 | |||
|
| |||||||
| Included patients | 2656 | 1341 | 1128 | ||||
| EQ-5D score (SD) | 0.73 (0.22) | 0.73 (0.22) | 0.73 (0.22) | .6838 | |||
|
| |||||||
| Age (SD) | 67.5 (10.1) | 67.9 (10.2) | 67.1 (9.9) | .0543 | |||
| Gender (female) (%) | 809 (30.5) | 405 (30.2) | 360 (31.9) | .3590 | |||
| Marital status (single) (%) | 623 (23.5) | 305 (22.7) | 279 (24.7) | .2465 | |||
| Years of education (< = 9 years) (%) | 841 (31.7) | 491 (36.6) | 289 (25.6) | <.0001 | |||
| Number of other conditions (SD) | 3.49 (1.79) | 3.55 (1.86) | 3.36 (1.70) | .0100 | |||
| Body mass index (> = 30) (%) | 610 (23.0) | 270 (20.1) | 291 (25.8) | .0008 | |||
|
| |||||||
| Being patient in practice | .0098 | ||||||
| – up to 2 years (%) | 119 (4.5) | 46 (3.4) | 63 (5.6) | ||||
| – 3–7 years (%) | 346 (13.0) | 187 (13.9) | 130 (11.5) | ||||
| – more than 7 years (%) | 2191 (82.5) | 1108 (82.6) | 935 (82.9) | ||||
| Practice attendance within 12 months | <.0001 | ||||||
| – up to 3 times (%) | 737 (27.7) | 316 (23.6) | 381 (33.8) | ||||
| – 4–7 times (%) | 1189 (44.8) | 589 (43.9) | 489 (43.4) | ||||
| – more than 7 times (%) | 730 (27.5) | 436 (32.5) | 258 (22.9) | ||||
| Referral to exercise program (yes) (%) | 1273 (47.9) | 660 (49.2) | 529 (46.9) | .2505 | |||
| Medication adherence (SD) | 3.49 (0.81) | 3.47 (0.85) | 3.52 (0.78) | .1702 | |||
| Patient satisfaction (EUROPEP) | |||||||
| – clinical behavior (SD) | 4.44 (0.66) | 4.44 (0.63) | 4.44 (0.70) | .8626 | |||
| – organization of care (SD) | 4.39 (0.68) | 4.43 (0.63) | 4.33 (0.74) | .0003 | |||
= T-Test (Single vs. Group);
= Chi2 (Single vs. Group); CVD: Cardiovascular disease.
Fixed part results of the random intercept model with overall EQ-5D score as dependent variable (2656 patients within 228 GPs within 8 countries), including all variables on patient and practice-level.
| Total sample | Single practices | Group practices | |||||||
| coeff. | (SE) | p-value | coeff. | (SE) | p-value | coeff. | (SE) | p-value | |
| Intercept | 0.7047 | (0.0467) | <.0001 | 0.8296 | (0.0640) | <.0001 | 0.6009 | (0.0667) | <.0001 |
|
| |||||||||
| CVD-care score | −0.0017 | (0.0017) | .3185 | −0.0032 | (0.0024) | .1786 | −0.0011 | (0.0025) | .6517 |
| Quality-management score | 0.0021 | (0.0018) | .2231 | 0.0028 | (0.0025) | .2759 | 0.0011 | (0.0025) | .6697 |
|
| |||||||||
|
| |||||||||
| Age (5-years unit) | −0.0064 | (0.0019) | .0008 | −0.0101 | (0.0027) | .0001 | −0.0036 | (0.0030) | .2374 |
| Gender (female) | −0.0543 | (0.0083) | <.0001 | −0.0439 | (0.0118) | .0002 | −0.0662 | (0.0125) | <.0001 |
| Marital status (single) | −0.0142 | (0.0088) | .1074 | −0.0294 | (0.0127) | .0205 | −0.0037 | (0.0133) | .7808 |
| Years of education (< = 9 years in school) | −0.0381 | (0.0083) | <.0001 | −0.0471 | (0.0112) | <.0001 | −0.0296 | (0.0137) | .0304 |
| Number of other conditions | −0.0340 | (0.0022) | <.0001 | −0.0367 | (0.0030) | <.0001 | −0.0319 | (0.0035) | <.0001 |
| Body mass index (> = 30) | −0.0211 | (0.0086) | .0145 | −0.0127 | (0.0127) | .3165 | −0.0279 | (0.0130) | .0314 |
|
| |||||||||
| Being patient in practice | .0473 | .0320 | .5838 | ||||||
| – up to 2 years | −0.0214 | (0.0176) | −0.0394 | (0.0280) | −0.0256 | (0.0248) | |||
| – 3–7 years | −0.0250 | (0.0110) | −0.0352 | (0.0150) | −0.0041 | (0.0181) | |||
| – more than 7 years |
|
|
| ||||||
| Practice attendance within 12 months | <.0001 | <.0001 | <.0001 | ||||||
| – up to 3 times | 0.1210 | (0.0109) | 0.0940 | (0.0156) | 0.1566 | (0.0165) | |||
| – 4–7 times | 0.0801 | (0.0091) | 0.0731 | (0.0126) | 0.0910 | (0.0146) | |||
| – more than 7 times |
|
|
| ||||||
| Referral to exercise program (yes) | 0.0240 | (0.0075) | .0013 | 0.0135 | (0.0107) | .2047 | 0.0394 | (0.0115) | .0006 |
| Medication adherence | 0.0195 | (0.0045) | <.0001 | 0.0179 | (0.0062) | .0039 | 0.0180 | (0.0072) | .0117 |
| Patient satisfaction (EUROPEP) | |||||||||
| – clinical behavior | 0.0282 | (0.0076) | .0002 | 0.0335 | (0.0114) | .0034 | 0.0324 | (0.0111) | .0035 |
| – organization of care | −0.0032 | (0.0075) | .6737 | −0.0142 | (0.0116) | .2194 | 0.0007 | (0.0109) | .9523 |
coeff.: regression coefficient, SE: standard error, CVD: Cardiovascular disease.
2656 patients, 228 practices, 8 countries.
1341 patients, 113 practices, 8 countries.
1128 patients, 102 practices, 8 countries.
Random part of all three random intercept models with overall EQ-5D score as dependent variable (2656 individuals within 228 GPs within 8 countries).
| All practices | Single-handed practice | Group practice | |||||||
| VC | (SE) | EV | VC | (SE) | EV | VC | (SE) | EV | |
|
| |||||||||
| Countries | 0.0038 | (0.0020) | 0.0034 | (0.0020) | 0.0047 | (0.0028) | |||
| Practices | 0.0029 | (0.0006) | 0.0036 | (0.0010) | 0.0020 | (0.0009) | |||
| Patients (plus random) | 0.0405 | (0.0012) | 0.0411 | (0.0017) | 0.0428 | (0.0019) | |||
|
| |||||||||
| Countries | 0.0037 | (0.0020) | 2.90% | 0.0032 | (0.0019) | 5.62% | 0.0044 | (0.0026) | 6.01% |
| Practices | 0.0029 | (0.0006) | 0.34% | 0.0034 | (0.0010) | 3.93% | 0.0021 | (0.0009) | NA |
| Patients (plus random) | 0.0405 | (0.0012) | 0.00% | 0.0411 | (0.0017) | NA | 0.0428 | (0.0019) | 0.05% |
|
| |||||||||
| Countries | 0.0033 | (0.0017) | 13.19% | 0.0023 | (0.0013) | 32.25% | 0.0039 | (0.0223) | 16.74% |
| Practices | 0.0014 | (0.0004) | 52.07% | 0.0012 | (0.0006) | 67.42% | 0.0014 | (0.0007) | 27.92% |
| Patients (plus random) | 0.0347 | (0.0010) | 14.36% | 0.0342 | (0.0014) | 16.70% | 0.0369 | (0.0016) | 13.83% |
|
| |||||||||
| Countries | 0.0026 | (0.0014) | 31.40% | 0.0016 | (0.0010) | 52.37% | 0.0018 | (0.0011) | 61.37% |
| Practices | 0.0011 | (0.0004) | 62.07% | 0.0011 | (0.0005) | 69.38% | 0.0006 | (0.0005) | 69.04% |
| Patients (plus random) | 0.0326 | (0.0009) | 19.55% | 0.0327 | (0.0013) | 20.35% | 0.0335 | (0.0015) | 21.66% |
VC: Variance component, SE: standard error, EV: explained variance, NA: not available.
Figure 2Proportion of variance in overall EQ-5D score explained at each level.